The University of Michigan at Ann Arbor is receiving $258,717,781 in federal healthcare grant funding supporting research across areas including cancer, aging, infectious diseases, cardiovascular diseases and other medical fields.
U.S. Representative Debbie Dingell said the funding comes from the U.S. Department of Health and Human Services (HHS) and was secured following her advocacy for federal resources supporting the university’s research programs.
The funding covers a broad range of scientific and healthcare initiatives at the university.
Among the specifically identified awards are $7.17 million for cancer research, approximately $1.52 million for allergy and infectious diseases research, nearly $1.17 million for diabetes, digestive and kidney disease research, and more than $1.02 million for cardiovascular disease research.
Additional funding includes approximately $1.35 million for neuroscience and neurological disorders research, $629,003 for oral diseases and disorders research, $610,843 for arthritis, musculoskeletal and skin diseases research, $598,644 for child health and human development research, and $562,696 for aging research.
Other supported areas include nursing research, human genome research, biomedical research and research training, minority health and health disparities, opioid programs, vision research, blood diseases, alcohol research and sickle cell data collection.
The funding adds to the University of Michigan’s position as a major U.S. research institution and will support programs intended to advance treatments, scientific discovery and patient outcomes.
KEY QUOTES:
“These funds are a critical step in improving the health and well-being of communities in Michigan and across the country. These grants will bolster the University of Michigan’s leadership in research and innovation. I am proud to have secured this money and will always work to deliver our state federal resources that lead to better treatments and patient outcomes.”
U.S. Representative Debbie Dingell
